Fetal Bovine Serum Market Size, Share, Analysis Report

Fetal Bovine Serum Market By Product Type Analysis (Charcoal stripped FBS, Chromatographic purified for low antibody FBS, Dialyzed FBS, Stem cell qualified FBS, Exosome depleted FBS); By Application Analysis (Antibody production, Veterinary applications, Cell culture maintenance, Exosome studies, Immunoassays) By End User Analysis (Research/academic institutes, Diagnostic labs, Cell banks) and by regional analysis - global forecast by

The Global Fetal bovine serum Market is expected to exceed more than US$ 1008 million by 2028 at a CAGR 5% in the given forecast period.

Purchase User License

MARKET SNAPSHOT

Major Players

  • Sigma-Aldrich Co. LLC.,
  • GE Healthcare,
  • Thermo Fisher Scientific Inc.,
  • TCS Biosciences Ltd
  • Study period:

    2023-2028

    Base Year:

    2021

    CAGR:

    5

    Fastest Growing Market:

    APAC

    Largest Market:

    North America

    REPORT DESCRIPTION

    Fetal Bovine Serum is a critical raw material for several research areas, animal health, biotechnology and pharmaceutical industry. Fetal bovine Serum is a mainly utilized serum supplement for the in-vitro-cell culture, because it has a very low level of antibodies and containing more growth factors. It allows versatility in many various cell culture applications. Fetal Bovine Serum boosts cell cycle and cell metabolism; it is also an important component of the nutrients which includes hormones, vitamins and nutrients. As Fetal bovine Serum is dependent on environmental conditions which are affecting the increase in product cost.

    How Big is The Global Fetal Bovine Serum Market?

    The Global Fetal bovine serum Market is expected to exceed more than US$ 1008 million by 2028 at a CAGR 5% in the given forecast period.

    The major driving factors of Global Fetal Bovine Serum Market are as follows:

    • Easy for regulatory approvals
    • Cost effective

    The restraining factors of ­Global Fetal bovine Serum Market are as follows:

    • No replacement of FBS
    • Dependent on environmental conditions
    • Ethical problems relating to blood collection method

    The global fetal bovine serum market has been segmented based on region of origin, specialty product type, application and end-user. In terms of specialty product type, the global fetal bovine serum market has been segmented into charcoal stripped FBS, chromatographic purified for low antibody FBS, dialyzed FBS, stem cell qualified FBS, exosome depleted FBS, and others. Stem cell qualified FBS is further divided into embryonic stem cells qualified FBS, mesenchymal stem cell-qualified FBS, and others. Based on application, the global fetal bovine serum market has been segmented into antibody production, veterinary applications, cell culture maintenance, exosome studies, immunoassays, and others. The immunoassays segment has been sub-segmented into radiolabeling assays, insulin assay methods, and others. In terms of end-user, the global fetal bovine serum market has been categorized into research/academic institutes, diagnostic labs, cell banks (stem cell banks, tumor cell banks, blood bank, etc.), biopharmaceutical companies, and others.

    This report provides:
    1) An overview of the global market for Fetal Bovine Serum and related technologies.
    2) Analyses of global market trends, with data from 2021, estimates for 2022 and 2023, and projections of compound annual growth rates (CAGRs) through 2028.
    3) Identifications of new market opportunities and targeted promotional plans for Global Fetal Serum Bovine Market.
    4) Discussion of research and development, and the demand for new products and new applications.
    5) Comprehensive company profiles of major players in the industry.

    Report scope:

    The scope of the report includes a detailed study of global and regional markets on Fetal Bovine Serum Market with the reasons given for variations in the growth of the industry in certain regions.
    The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Sigma-Aldrich Co. LLC., GE Healthcare, Thermo Fisher Scientific Inc., TCS Biosciences Ltd., HiMedia Laboratories, Atlanta Biologicals, Inc., PAN-Biotech, Rocky Mountain Biologicals, BovogenBiologicals Pty Ltd., and Tissue Culture Biologicals, among others. Company profile includes such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
     
    The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.

    The Global Fetal Bovine Serum Market has been segmented as below:

    By Product Type Analysis:

    • Charcoal stripped FBS
    • Chromatographic purified for low antibody FBS
    • Dialyzed FBS
    • Stem cell qualified FBS
    • Embryonic stem cells qualified FBS
    • Mesenchymal stem cell-qualified FBS
    • Others
    • Exosome depleted FBS
    • Others

    By Application Analysis:

    • Antibody production
    • Veterinary applications
    • Cell culture maintenance
    • Exosome studies
    • Immunoassays
    • Radiolabeling assays
    • Insulin assay methods
    • Others
    • Others

    By End User Analysis:

    • Research/academic institutes
    • Diagnostic labs
    • Cell banks

    By Regional Analysis:

    • North America
    • Europe
    • Asia-Pacific
    • Rest of the World

    Reasons to Buy this Report:
    1) Obtain the most up to date information available on all Global Fetal Bovine Serum Market.
    2) Identify growth segments and opportunities in the industry.
    3) Facilitate decision making on the basis of strong historic and forecast of Global Fetal Bovine Serum Market data.
    4) Assess your competitor’s refining portfolio and its evolution.

    Customization:
    We can offer you custom research reports as per client’s special requirements

    Below are our New Reports :-

    Macrolide Drugs market

    Livestock Vaccine market

    Liquid Biopsy Market

    Liothyronine Market

    Medical non-woven disposable market

    Request For TOC

    The Global Fetal Bovine Serum Market has been segmented as below:

    By Product Type Analysis:

    • Charcoal stripped FBS
    • Chromatographic purified for low antibody FBS
    • Dialyzed FBS
    • Stem cell qualified FBS
    • Embryonic stem cells qualified FBS
    • Mesenchymal stem cell-qualified FBS
    • Others
    • Exosome depleted FBS
    • Others

    By Application Analysis:

    • Antibody production
    • Veterinary applications
    • Cell culture maintenance
    • Exosome studies
    • Immunoassays
    • Radiolabeling assays
    • Insulin assay methods
    • Others
    • Others

    By End User Analysis:

    • Research/academic institutes
    • Diagnostic labs
    • Cell banks

     

    By Regional Analysis:

    • North America
    • Europe
    • Asia-Pacific
    • Rest of the World

    Got a question? We've got answers. If you have some other questions, see our support center.

    The market is expected to grow at a CAGR of 5% during the study period (2023-2028)
    The Global Fetal bovine serum Market is expected to exceed more than US$ 1008 million by 2028 in the given forecast period
    The segment included in the Fetal bovine serum Market is Product, Application, End User and region.
    Some key players operating in the Fetal bovine serum Market include Sigma-Aldrich Co. LLC., GE Healthcare, Thermo Fisher Scientific Inc., TCS Biosciences Ltd
    We can offer several formats of the market research reports including, • PDF • PPT • Spreadsheet/ Workbook

    Related Reports